Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07451158
Eligibility Criteria:
Inclusion Criteria:
* Male or female, aged between 18 and 75;
* According to the diagnostic criteria of the International Classification of Headache Disorders (ICHD-III), the diagnosis is episodic migraine with or without aura or probable migraine with or without aura;
* The duration of the illness is at least 12 months;
* The age of onset of the first migraine is less than 50 years old;
* During the screening period of 4 weeks, there were 2-8 episodes of headache, with moderate or severe pain intensity;
* Before screening, the subjects should provide their previous medical records as much as possible;
* Participants can distinguish migraines from other conditions, including tension-type headaches and cluster headaches
* Understand and adhere to the research procedures and methods, voluntarily participate in this trial, and sign the informed consent form in writing;
Exclusion Criteria:
* Pregnant and lactating women;
* Suffering from arrhythmia or other heart diseases (such as ischemic heart disease, coronary artery spasm, myocardial infarction, acute coronary syndrome, percutaneous coronary intervention, angina pectoris);
* Have undergone surgery within the past 6 months;
* Recent stroke or transient ischemic attack;
* Equipped with a pacemaker;
* History of previous seizures;
* Metal implants in the head;
* Patients with clinical evidence of brain damage;
* Chronic pain associated with other diseases;
* Use antipsychotic drugs;
* Those who are intolerant to neuroregulators;
* Employees of the research center or their immediate family members.
* There is a condition or anomaly that the investigator believes may affect patient safety or data quality
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07451158
Study Brief:
Protocol Section:
NCT07451158